BeiGene (BGNE) Stock Highlights

199.85 | +1.3%

2024-09-19 15:42:23

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Brutons tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

Statistics

Range Today

197.76 200.49

Volume Today 54.08K

Range 1 Year

126.97 215

Volume 1 Year 61.02M

Range 3 Year

118.18 413.33

Volume 3 Year 190.24M

Range 10 Year

22.51 426.56

Volume 10 Year 588.22M

Highlights

Market Capitalization 21.5B (large)

Floating Shares 783.82M

Current Price 199.85

Price To Earnings -40

Price To Revenue 87.94

Price To Book 6.26

Earnings Per Share -5

Payout Ratio 0%

Performance

Latest +1.3%

1 Month +3.69%

3 Months +30.09%

6 Months +18.74%

1 Year -4.49%

3 Years -49.02%

5 Years +52.7%

10 Years +589.85%

Benchmarks

Market Capitalization

7 / 368

Gross Profits

276 / 278

Total Revenue

9 / 300

Total Rank

217 / 368

Free Cashflow

352 / 352

Performance 5 years

92 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.